​

Funding Round

Series A - Zephyr AI

Series A - Zephyr AI

Investment Firm

Overview

Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.

Announced Date

Mar 13, 2024

Closed on Date

Mar 13, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Eli Lilly & Company Foundation

Eli Lilly & Company Foundation

No designation

Revolution Growth

Revolution Growth

Revolution Growth is a early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

2

Investor Name
Participant InvestorRevolution Growth
Participant InvestorEli Lilly & Company Foundation

Round Details and Background

Zephyr AI raised $111000000 on 2024-03-13 in Series A

Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 30, 2022
Seed Round - Zephyr AI
7-18.5M
Mar 13, 2024
Series A - Zephyr AI
4-111.0M

Recent Activity

There is no recent news or activity for this profile.